BioPlus Acquisition Corp. is an early stage blank check company, which engages in effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. It focuses on identifying an opportunity in the life sciences industry. The company was founded on February 11, 2021 and is headquartered in New York, NY.
Sector:
Finance
Industry:
Financial Conglomerates
Employees:
N/A
Frequently Asked Questions
What is Market Cap of BioPlus Acquisition Corp - Ordinary Shares - Class A?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. BioPlus Acquisition Corp - Ordinary Shares - Class A market cap is $316.4M.
What is the 52-week high for BioPlus Acquisition Corp - Ordinary Shares - Class A?
52 week high is the highest price of a stock in the past 52 weeks, or one year. BioPlus Acquisition Corp - Ordinary Shares - Class A 52 week high is $11.68 as of September 28, 2025.
What is the 52-week low for BioPlus Acquisition Corp - Ordinary Shares - Class A?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. BioPlus Acquisition Corp - Ordinary Shares - Class A 52 week low is $10.05 as of September 28, 2025.
What is BioPlus Acquisition Corp - Ordinary Shares - Class A stock price today?
BioPlus Acquisition Corp - Ordinary Shares - Class A stock price today is $10.80.
What was BioPlus Acquisition Corp - Ordinary Shares - Class A stock price yesterday?
BioPlus Acquisition Corp - Ordinary Shares - Class A stock price yesterday was $10.79.
What is the PE ratio of BioPlus Acquisition Corp - Ordinary Shares - Class A?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. BioPlus Acquisition Corp - Ordinary Shares - Class A’s P/E ratio is 52.40.
What is the Price-to-Book ratio of BioPlus Acquisition Corp - Ordinary Shares - Class A?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. BioPlus Acquisition Corp - Ordinary Shares - Class A P/B ratio is 2.5966.
What is BioPlus Acquisition Corp - Ordinary Shares - Class A's EBITDA?
EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. BioPlus Acquisition Corp - Ordinary Shares - Class A's EBITDA is -122.97.
What is the 50-day moving average of BioPlus Acquisition Corp - Ordinary Shares - Class A?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. BioPlus Acquisition Corp - Ordinary Shares - Class A 50-day moving average is $10.77.
